PE20200383A1 - Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados - Google Patents

Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados

Info

Publication number
PE20200383A1
PE20200383A1 PE2019001790A PE2019001790A PE20200383A1 PE 20200383 A1 PE20200383 A1 PE 20200383A1 PE 2019001790 A PE2019001790 A PE 2019001790A PE 2019001790 A PE2019001790 A PE 2019001790A PE 20200383 A1 PE20200383 A1 PE 20200383A1
Authority
PE
Peru
Prior art keywords
purified
terpens
compositions including
cannabinoids
selected compositions
Prior art date
Application number
PE2019001790A
Other languages
English (en)
Inventor
Kurt Levy
Jonathan Michael Cooper
Jonathan Reed Martin
Brian Geoffrey Reid
Original Assignee
Canopy Growth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/616,874 external-priority patent/US20170266153A1/en
Application filed by Canopy Growth Corp filed Critical Canopy Growth Corp
Publication of PE20200383A1 publication Critical patent/PE20200383A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)

Abstract

Referido a una composicion que comprende un primer cannabinoide purificado; y un compuesto elegido de un segundo cannabinoide purificado o un primer terpeno purificado. En donde el primer terpeno purificado se elige entre 7,8-dihidro-alfa-ionona, acetanisol, limoneno, entre otros; el primer cannabinoide purificado se elige entre acido cannabigerolico (CBGA), cannabigerol (CBG), tetrahidrocannabinol (THC), entre otros. En donde dicha composicion tiene una pureza superior al 80 % y su formulacion comprende combinaciones intencionalmente disenadas de proporciones y concentraciones no naturales.
PE2019001790A 2017-03-01 2018-03-01 Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados PE20200383A1 (es)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US201762465688P 2017-03-01 2017-03-01
US201762469415P 2017-03-09 2017-03-09
US201762475153P 2017-03-22 2017-03-22
US201762477990P 2017-03-28 2017-03-28
US201762489360P 2017-04-24 2017-04-24
US201762490465P 2017-04-26 2017-04-26
US201762490567P 2017-04-26 2017-04-26
US201762491160P 2017-04-27 2017-04-27
US201762491175P 2017-04-27 2017-04-27
US201762491899P 2017-04-28 2017-04-28
US201762491980P 2017-04-28 2017-04-28
US201762509651P 2017-05-22 2017-05-22
US201762510229P 2017-05-23 2017-05-23
US201762510660P 2017-05-24 2017-05-24
US201762510672P 2017-05-24 2017-05-24
US201762511218P 2017-05-25 2017-05-25
US15/616,874 US20170266153A1 (en) 2015-02-27 2017-06-07 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
PCT/US2018/020440 WO2018160827A1 (en) 2017-03-01 2018-03-01 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes

Publications (1)

Publication Number Publication Date
PE20200383A1 true PE20200383A1 (es) 2020-02-24

Family

ID=63370542

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2019001790A PE20200383A1 (es) 2017-03-01 2018-03-01 Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados

Country Status (10)

Country Link
EP (1) EP3589129A4 (es)
CN (1) CN110582206A (es)
AU (1) AU2018227544A1 (es)
BR (1) BR112019018088A2 (es)
CA (1) CA3054690A1 (es)
CO (1) CO2019009413A2 (es)
IL (1) IL268929A (es)
MX (1) MX2019010370A (es)
PE (1) PE20200383A1 (es)
WO (1) WO2018160827A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3031123C (en) 2018-01-23 2023-11-07 High Sierra Technologies, Inc. Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons
IL266151A (en) * 2019-04-18 2019-07-31 Kanabo Res Ltd Dilute for the cannabinoid preparations
CA3148236A1 (en) 2019-07-22 2021-01-28 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
BR112022010288A2 (pt) * 2019-11-26 2022-09-27 Lycored Ltd Combinações sinérgicas anti-inflamatórias de canabinoide e licopeno
AU2021264109A1 (en) * 2020-04-29 2022-12-08 Ligar Limited Partnership Imprinted polymers and methods for their use
US20230146330A1 (en) * 2020-07-27 2023-05-11 Canopy Growth Corporation Methods of synthesizing cannabielsoin and analogs thereof
WO2022165165A1 (en) * 2021-01-29 2022-08-04 The Johns Hopkins University Limonene effects on tetrahydrocannabinol (thc)-induced anxiety
CN113368086B (zh) * 2021-08-11 2021-12-03 龙麻(上海)医药研发有限责任公司 一种***素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
WO2023245185A1 (en) * 2022-06-17 2023-12-21 New Growth Brands, Inc. Compositions comprising cannabinoids and methods of preparation and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) * 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物***素次***二酚（ｃｂｄｖ）來治療癲癇之用途
ES2784229T3 (es) * 2013-11-20 2020-09-23 Panag Pharma Inc Composiciones y procedimientos para el tratamiento de la inflamación y el dolor ocular
WO2016138505A1 (en) * 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral

Also Published As

Publication number Publication date
EP3589129A1 (en) 2020-01-08
CN110582206A (zh) 2019-12-17
CA3054690A1 (en) 2018-09-07
IL268929A (en) 2019-10-31
WO2018160827A1 (en) 2018-09-07
CO2019009413A2 (es) 2019-09-09
MX2019010370A (es) 2019-10-22
BR112019018088A2 (pt) 2020-03-24
AU2018227544A1 (en) 2019-08-29
EP3589129A4 (en) 2020-11-25

Similar Documents

Publication Publication Date Title
PE20200383A1 (es) Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados
PE20190318A1 (es) Composicion administrable oralmente
CL2022003510A1 (es) Inhibidores de cisteína proteasas y sus métodos de uso
EA202092582A1 (ru) Препараты каннабидиола и их применение
PE20200676A1 (es) Composicion de cannabis
SV1999000072A (es) Composiciones estabilizadas
ES2721148T3 (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
MA42678B1 (fr) Nouveaux analogues nucléosidiques substitués à cycle aromatique bicyclique 6-6 pour une utilisation en tant qu'inhibiteurs de prmt5
CL2017001983A1 (es) Composiciones farmacéuticas para terapia combinada.
BRPI0717970B8 (pt) composto inibidor de 11betahsd1, composição farmacêutica, e, uso do composto
BR112019024785A2 (pt) composto de bifenila ou sal do mesmo, composição farmacêutica, agente antineoplásico e uso
NI200500090A (es) Compuestos de benzofurano, composiciones y metodos para tratamiento y profilafixis de infecciones virales de hepatitis c y enfermedades asociadas
CO6220926A2 (es) Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid)
AR063555A1 (es) Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos
BR112014029754B1 (pt) soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição
CR11316A (es) Derivado de uracilo o timina para el tratamiiento de la hepatitis c.
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
BR112017015032A2 (pt) composições curáveis e membranas
ECSP11010755A (es) Povidona yodada, una nueva alternativa conservante para composiciones oftálmicas
BRPI0410660A (pt) derivados de 2-amino-piridina como agonistas de adrenoreceptor ß2
NO20062696L (no) Molluskisid og anti-gro forbindelser
ATE485261T1 (de) Salicylsäurederivate
WO2012071389A3 (en) Stable cannabinoid compositions and methods for making and storing them
AR059927A1 (es) Metodos para la estabilizacion de composiciones inestables a la oxidacion y composiciones oftalmicas estabilizadas
BR112018012952A2 (pt) composições para higiene pessoal